Validity of EQ-5D-5L in stroke

Golicki, Dominik; Niewada, Maciej; Buczek, Julia; Karlińska, A; Kobayashi, Adam; Janssen, Mathieu F.; Pickard, A. Simon

doi:10.1007/s11136-014-0834-1

Cited by 191 publications

(173 citation statements)

References 22 publications

Supporting

Mentioning

165

Contrasting

Order By: Relevance

“…Some countries have already started its evaluation, e.g. Golicki et al [37], and it is likely we will use the updated versions in future studies once validated.…”

Section: Discussionmentioning

confidence: 99%

Quality of life of patients with Diabetes Mellitus Types 1 and 2 from a referal health centre in Minas Gerais, Brazil

Mata

Álvares

Diniz

et al. 2016

Expert Review of Clinical Pharmacology

View full text Add to dashboard Cite

This version is available at https://strathprints.strath.ac.uk/55487/ Strathprints is designed to allow users to access the research output of the University of Strathclyde. Unless otherwise explicitly stated on the manuscript, Copyright © and Moral Rights for the papers on this site are retained by the individual authors and/or other copyright owners. Please check the manuscript for details of any other licences that may have been applied. You may not engage in further distribution of the material for any profitmaking activities or any commercial gain. You may freely distribute both the url (https://strathprints.strath.ac.uk/) and the content of this paper for research or private study, educational, or not-for-profit purposes without prior permission or charge.Any correspondence concerning this service should be sent to the Strathprints administrator: strathprints@strath.ac.ukThe Strathprints institutional repository (https://strathprints.strath.ac.uk) is a digital archive of University of Strathclyde research outputs. It has been developed to disseminate open access research outputs, expose data about those outputs, and enable the management and persistent access to Strathclyde's intellectual output. 1 QUALITY OF LIFE OF PATIENTS WITH DIABETES MELLITUS TYPES 1 AND 2 FROM A REFERRAL HEALTH CARE CENTER IN MINAS GERAIS, BRAZIL.

show abstract

“…Some countries have already started its evaluation, e.g. Golicki et al [37], and it is likely we will use the updated versions in future studies once validated.…”

Section: Discussionmentioning

confidence: 99%

Quality of life of patients with Diabetes Mellitus Types 1 and 2 from a referal health centre in Minas Gerais, Brazil

Mata

Álvares

Diniz

et al. 2016

Expert Review of Clinical Pharmacology

View full text Add to dashboard Cite

show abstract

“…We also currently do not know how different mRS categories are with respect to QoL in the long run. The EQ5D-3L is a 15-item self-reported simple, generic measure of health-related QoL with well-established psychometric properties in the European and US populations and is a frequently used general health status questionnaire in stroke patients [5,6,7]. The goal of this analysis of the Interventional Management of Stroke 3 (IMS3) trial was to compare outcomes at 3 months after stroke using the Barthel index (BI) and health-related QoL (EQ5D-3L summary index), across the mRS 0-5 categories.…”

Section: Introductionmentioning

confidence: 99%

Comparison of 3-Month Stroke Disability and Quality of Life across Modified Rankin Scale Categories

et al. 2016

View full text Add to dashboard Cite

Background and Purpose: Modified Rankin Scale (mRS) score 0-2 has been used to define “good outcome” while stroke patients with mRS 3 are grouped with mRS 4-6 as having “poor outcome.” Long-term data comparing quality of life (QoL), particularly across the mRS 2, 3, and 4 subgroups, are sparse. Methods: Participants in the Interventional Management of Stroke 3 (IMS3) trial with documented 3-month mRS, functional disability (Barthel index [BI]), and self-reported EQ5D-3L QoL questionnaires at 3 months after stroke were included. EQ5D-3L summary indices were calculated using published utility weights for the US population. BI and EQ5D-3L indices were compared across mRS categories using multiple pairwise comparisons with appropriate alpha error corrections. Results: Four hundred twenty-three patients were included (mean age 64 ± 13 years, median baseline NIHSS 16 [IQR 12-19], mean BI 84.1 ± 25.3, and mean EQ5D-3L index 0.73 ± 0.24). While significant differences in BI were observed across mRS categories, QoL in the mRS 2 and 3 categories was similar. Based on BI and EQ5D-3L index, mRS 3 status was more similar to mRS 2 than to mRS 4 status, and large heterogeneity in the mRS 3 group was observed. Conclusions: Ischemic stroke patients who achieve mRS 2 and 3 functional outcomes seem to have similar health-related QoL scores. mRS 0-3, rather than 0-2, should be considered a good outcome category in moderate to severe ischemic stroke.

show abstract

“…Within the UK, the EuroQol-5D (EQ-5D) is the most commonly used preference-based measure [3], and the one recommended by NICE for HTA submissions [4]. Since 2011, a five-level version of the EQ-5D (EQ-5D-5L) has replaced the previous three-level version (EQ-5D-3L) [5], and emerging evidence indicates improved psychometric performance [6][7][8][9].…”

Section: Introductionmentioning

confidence: 99%

“…Despite the positive emerging evidence for the psychometric properties of the ICECAP-A [32][33][34][35] and EQ-5D-5L [6][7][8][9], no evidence is yet available for the context of opiate dependence. Even though some supporting evidence for the EQ-5D-3L and other similar health-focused measures exists for this context [36][37][38][39], such measures are used with caution in economic evaluations [40,41].…”

Section: Introductionmentioning

confidence: 99%

Measuring Health and Broader Well-Being Benefits in the Context of Opiate Dependence: The Psychometric Performance of the ICECAP-A and the EQ-5D-5L

et al. 2016

View full text Add to dashboard Cite

2 Key points What is already known about the topic? Treatments for substance use disorders aim at improving health and, most importantly, broader wellbeing. Health-related measures of quality of life may not adequately capture the broader wellbeing benefits associated with such complex interventions. Comprehensive evidence on the validity and responsiveness of these measures in this context is lacking. When broader capability-wellbeing benefits are expected, NICE recommends the parallel use of an ICECAP measure but their measurement properties in this context are yet unknown. What does the paper add to existing knowledge? This is the first study exploring the psychometric properties of the EQ-5D-5L and ICECAP-A measures in the context of drug addiction. The results indicate that the ICECAP-A is a promising measure for capturing both health and broader wellbeing benefits in this context. 3 ABSTRACT Background:Measuring outcomes in economic evaluations of social care interventions is

show abstract

Validity of EQ-5D-5L in stroke

Cited by 191 publications

References 22 publications

Quality of life of patients with Diabetes Mellitus Types 1 and 2 from a referal health centre in Minas Gerais, Brazil

Quality of life of patients with Diabetes Mellitus Types 1 and 2 from a referal health centre in Minas Gerais, Brazil

Comparison of 3-Month Stroke Disability and Quality of Life across Modified Rankin Scale Categories

Measuring Health and Broader Well-Being Benefits in the Context of Opiate Dependence: The Psychometric Performance of the ICECAP-A and the EQ-5D-5L

Contact Info

Product

Resources

About